NASDAQ:JNCE
Jounce Therapeutics, Inc.
- Stock
Last Close
1.88
03/05 20:00
Market Cap
98.95M
Beta: 0.75
Volume Today
11.60M
Avg: 3.15M
PE Ratio
−1.91
PFCF: −3.32
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||
average payables | 1.69M - | 3.06M 81.82% | 3.18M 3.77% | 3.06M 3.76% | 2.87M 6.36% | 2.25M 21.56% | 1.85M 17.48% | 1.88M 1.59% | ||
average receivables | 354.50K - | 9.21M 2,497.32% | 9.06M 1.60% | 207K 97.72% | ||||||
book value per share | -0.02 - | 2.42 10,099.42% | 2.38 1.61% | 5.56 133.34% | 3.20 42.49% | 5.28 65.07% | 5.96 13.01% | 4.48 24.85% | 3.54 20.95% | |
capex per share | -0.03 - | -0.12 275.71% | -0.07 38.03% | -0.50 582.30% | -0.04 91.70% | -0.03 28.64% | -0.00 91.09% | -0.01 181.54% | -0.02 138.06% | |
capex to depreciation | -0.63 - | -1.50 137.02% | -1.14 23.70% | -3.42 198.89% | -0.35 89.62% | -0.26 27.90% | -0.03 89.19% | -0.13 377.38% | -0.44 233.74% | |
capex to operating cash flow | 0.05 - | 0.09 82.47% | -0.01 114.45% | 0.17 1,446.37% | 0.02 87.17% | 0.03 53.03% | 0.00 89.65% | 0.00 32.06% | 0.03 612.38% | |
capex to revenue | -0.06 - | -0.21 252.99% | -0.02 90.12% | -0.01 68.04% | -0.00 77.36% | -0.01 820.26% | -0.01 19.23% | |||
cash per share | 0.11 - | 2.44 2,203.71% | 4.95 102.95% | 7.84 58.44% | 5.83 25.64% | 5.10 12.46% | 5.83 14.19% | 3.58 38.64% | 3.67 2.56% | |
days of inventory on hand | ||||||||||
days payables outstanding | ||||||||||
days sales outstanding | 6.96 - | 90.21 1,196.59% | 2.32 97.43% | |||||||
debt to assets | 1.07 - | 0.15 85.69% | 0.74 379.64% | 0.44 40.59% | 0.51 17.80% | 0.15 70.46% | 0.13 11.25% | 0.11 15.23% | 0.14 21.14% | |
debt to equity | -15.05 - | 0.18 101.20% | 2.77 1,433.13% | 0.78 72.06% | 1.06 36.66% | 0.18 83.09% | 0.16 13.00% | 0.13 17.20% | 0.16 24.54% | |
dividend yield | ||||||||||
earnings yield | -0.03 - | -0.09 223.59% | -0.03 70.51% | -0.04 62.93% | -0.25 481.37% | 0.20 178.87% | -0.18 189.85% | -0.22 23.28% | -0.89 307.28% | |
enterprise value | 378.71M - | 274.34M 27.56% | 475.45M 73.30% | 359.70M 24.34% | 61.91M 82.79% | 255.34M 312.46% | 117.38M 54.03% | 335.08M 185.47% | -83.19M 124.83% | |
enterprise value over ebitda | -40.25 - | -10.14 74.81% | -40.43 298.84% | -30.01 25.77% | -2.63 91.22% | 4.83 283.53% | -2.60 153.82% | -3.68 41.45% | 1.66 145.07% | |
ev to operating cash flow | -25.40 - | -10.66 58.04% | 2.65 124.82% | -3.96 249.82% | -0.97 75.45% | -8.47 770.85% | -4.22 50.16% | -4.01 4.99% | 2.88 171.78% | |
ev to sales | 12.78 - | 5.02 60.72% | 0.95 81.09% | 1.73 81.87% | 1.88 9.04% | 12.47 562.06% | -1.01 108.14% | |||
free cash flow per share | -0.71 - | -1.51 113.50% | 5.88 490.03% | -3.52 159.85% | -2.00 43.35% | -0.94 52.85% | -0.79 16.32% | -1.68 113.41% | -0.58 65.67% | |
free cash flow yield | -0.04 - | -0.09 113.50% | 0.34 490.03% | -0.28 180.98% | -0.59 114.33% | -0.11 81.80% | -0.11 4.36% | -0.20 78.91% | -0.52 158.23% | |
graham net net | -0.26 - | 2.00 873.42% | -1.65 182.31% | 3.97 341.29% | 2.45 38.26% | 4.16 69.57% | 4.90 17.80% | 3.00 38.81% | 3.10 3.36% | |
graham number | 0.51 - | 9.16 1,698.80% | 4.94 46.13% | 8.27 67.63% | 7.78 6.00% | 14.28 83.65% | 12.89 9.77% | 13.55 5.13% | 8.86 34.58% | |
income quality | 1.42 - | 0.90 36.37% | -13.11 1,553.60% | 5.52 142.08% | 2.32 57.90% | -0.53 122.82% | 0.63 219.54% | 0.92 44.96% | 0.57 38.28% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -6.68 - | 9.62 243.94% | 30.09 212.80% | 35.83 19.08% | ||||||
interest debt per share | 0.36 - | 0.34 4.17% | 0.21 37.99% | 0.17 22.41% | ||||||
inventory turnover | ||||||||||
invested capital | 0.11 - | 0.08 29.48% | 0.06 23.48% | 0.05 10.53% | ||||||
market cap | 381.05M - | 319.50M 16.15% | 520.29M 62.84% | 383.20M 26.35% | 109.75M 71.36% | 288.79M 163.13% | 247.98M 14.13% | 416.92M 68.13% | 57.36M 86.24% | |
net current asset value | -5.18M - | 37.59M 825.01% | -47.65M 226.77% | 126.05M 364.50% | 81.89M 35.03% | 142.41M 73.91% | 178.45M 25.31% | 161.94M 9.25% | 167.79M 3.62% | |
net debt to ebitda | 0.25 - | 1.67 571.66% | 3.81 128.54% | 1.96 48.59% | 2.04 3.83% | -0.63 131.11% | 2.89 557.07% | 0.90 68.95% | 2.80 211.79% | |
net income per share | -0.48 - | -1.54 223.59% | -0.45 70.51% | -0.55 20.42% | -0.84 53.67% | 1.72 304.32% | -1.24 172.05% | -1.82 47.06% | -0.99 45.86% | |
operating cash flow per share | -0.67 - | -1.39 105.90% | 5.96 528.70% | -3.02 150.68% | -1.95 35.30% | -0.91 53.37% | -0.78 13.88% | -1.67 113.18% | -0.56 66.58% | |
payables turnover | ||||||||||
receivables turnover | 52.46 - | 4.05 92.29% | 157.49 3,792.19% | |||||||
research and ddevelopement to revenue | 0.94 - | 0.95 0.85% | 1.07 13.53% | 0.45 57.74% | 1.26 178.03% | 3.31 162.24% | 1.26 61.95% | |||
return on tangible assets | -1.40 - | -0.54 61.51% | -0.05 90.62% | -0.06 9.74% | -0.13 130.34% | 0.28 316.18% | -0.18 165.04% | -0.36 100.33% | -0.24 33.38% | |
revenue per share | 1.23 - | 2.38 93.29% | 2.00 16.01% | 4.47 123.28% | 1.76 60.63% | 0.54 69.41% | 1.59 194.76% | |||
roe | 19.66 - | -0.64 103.24% | -0.19 70.03% | -0.10 48.39% | -0.26 167.22% | 0.33 223.78% | -0.21 163.75% | -0.41 95.68% | -0.28 31.51% | |
roic | -7.77 - | 0.76 109.79% | -0.08 110.68% | -0.08 3.89% | -0.27 248.07% | 0.54 300.36% | 0.85 57.05% | -1.52 277.64% | 0.58 138.03% | |
sales general and administrative to revenue | 0.45 - | 0.32 28.56% | 0.41 26.00% | 0.19 53.44% | 0.46 144.39% | 1.08 133.67% | 0.38 64.97% | |||
shareholders equity per share | -0.02 - | 2.42 10,099.42% | 2.38 1.61% | 5.56 133.34% | 3.20 42.49% | 5.28 65.07% | 5.96 13.01% | 4.48 24.85% | 3.54 20.95% | |
stock based compensation to revenue | 0.13 - | 0.07 50.31% | 0.14 116.47% | 0.06 54.96% | 0.16 141.21% | 0.43 172.41% | 0.13 70.66% | |||
tangible asset value | -535K - | 44.86M 8,484.30% | 71.87M 60.23% | 167.11M 132.51% | 104.13M 37.69% | 174.59M 67.67% | 211.29M 21.02% | 223.81M 5.92% | 183.11M 18.18% | |
tangible book value per share | -0.02 - | 2.42 10,099.42% | 2.38 1.61% | 5.56 133.34% | 3.20 42.49% | 5.28 65.07% | 5.96 13.01% | 4.48 24.85% | 3.54 20.95% | |
working capital | 403K - | 38.99M 9,574.69% | 61.11M 56.75% | 193.05M 215.88% | 126.66M 34.39% | 159.30M 25.76% | 192.07M 20.57% | 171.93M 10.48% | 173.66M 1.01% |
All numbers in USD (except ratios and percentages)